Cancer
Autor Michael Dean, Karobi Moitraen Limba Engleză Paperback – 3 dec 2018
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 272.77 lei 6-8 săpt. | |
| Morgan & Claypool Life Sciences – 3 dec 2018 | 272.77 lei 6-8 săpt. | |
| Hardback (1) | 418.99 lei 6-8 săpt. | |
| Morgan & Claypool Life Sciences – 3 dec 2018 | 418.99 lei 6-8 săpt. |
Preț: 272.77 lei
Nou
Puncte Express: 409
Preț estimativ în valută:
52.21€ • 53.80$ • 44.08£
52.21€ • 53.80$ • 44.08£
Carte tipărită la comandă
Livrare economică 03-17 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781615047949
ISBN-10: 1615047948
Pagini: 84
Dimensiuni: 191 x 235 x 5 mm
Greutate: 0.18 kg
Editura: Morgan & Claypool Life Sciences
ISBN-10: 1615047948
Pagini: 84
Dimensiuni: 191 x 235 x 5 mm
Greutate: 0.18 kg
Editura: Morgan & Claypool Life Sciences
Notă biografică
Dr. Michael Dean obtained his Ph.D. from the Biochemistry Department at the Boston University School of Medicine. He performed his postdoctoral studies at the National Cancer Institute on the MET oncogene and the cystic fibrosis gene, and he is currently the Chief of the Laboratory of Translational Genomics at the National Cancer Institute.
Dr. Dean has published more than 200 research articles in peer-reviewed journals including Nature, Science, Cell, and the New England Journal of Medicine. In addition, he has authored numerous review articles and chapters in journals and books including those for the public, such as Scientific American, Nature Reviews, and Discovery Medicine. He is a member of the American Society of Human Genetics, Centre Etude du Polymorphisme Humaine (CEPH), the Human Genome Organization (HUGO), and an adjunct faculty member at Hood College.
Dr. Dean is the recipient of the Young Investigator Award from the American Association for Cancer Research and the National Institute of Health Director's Award. He holds more than 12 patents for the discovery of human disease genes.
Dr. Dean's current research interests include the genetic analysis of complex disease, genetic variation in human tumors, ABC transporters, age-related macular degeneration (AMD), and cancer stem cells. He is also actively involved in pediatric cancer research efforts in Latin America, including studies of childhood leukemia, retinoblastoma, cervical cancer, and health disparities among indigenous Mayan people of Guatemala.
Dr. Dean has published more than 200 research articles in peer-reviewed journals including Nature, Science, Cell, and the New England Journal of Medicine. In addition, he has authored numerous review articles and chapters in journals and books including those for the public, such as Scientific American, Nature Reviews, and Discovery Medicine. He is a member of the American Society of Human Genetics, Centre Etude du Polymorphisme Humaine (CEPH), the Human Genome Organization (HUGO), and an adjunct faculty member at Hood College.
Dr. Dean is the recipient of the Young Investigator Award from the American Association for Cancer Research and the National Institute of Health Director's Award. He holds more than 12 patents for the discovery of human disease genes.
Dr. Dean's current research interests include the genetic analysis of complex disease, genetic variation in human tumors, ABC transporters, age-related macular degeneration (AMD), and cancer stem cells. He is also actively involved in pediatric cancer research efforts in Latin America, including studies of childhood leukemia, retinoblastoma, cervical cancer, and health disparities among indigenous Mayan people of Guatemala.